PRICE T ROWE ASSOCIATES INC /MD/ - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$67,836
-89.5%
1,783,241
-74.8%
0.01%
-88.9%
Q2 2023$644,280
+112.8%
7,072,226
+54.1%
0.09%
+100.0%
Q1 2023$302,760
+112.9%
4,590,040
+66.9%
0.04%
+95.7%
Q4 2022$142,179
-99.9%
2,749,542
-17.9%
0.02%
-37.8%
Q3 2022$228,871,000
-41.7%
3,350,963
-61.4%
0.04%
-26.0%
Q2 2022$392,501,000
-2.0%
8,679,813
+10.1%
0.05%
+25.0%
Q1 2022$400,629,000
+59.9%
7,884,839
+48.8%
0.04%
+73.9%
Q4 2021$250,513,000
+58.1%
5,298,491
+10.2%
0.02%
+53.3%
Q3 2021$158,441,000
-51.5%
4,807,077
-7.0%
0.02%
-50.0%
Q2 2021$326,775,000
+109.1%
5,170,494
+42.0%
0.03%
+87.5%
Q1 2021$156,285,000
-10.3%
3,642,149
+19.6%
0.02%
-11.1%
Q4 2020$174,193,000
+93.9%
3,045,329
+2.2%
0.02%
+80.0%
Q3 2020$89,858,000
-9.1%
2,978,400
-1.6%
0.01%
-16.7%
Q2 2020$98,889,000
+195.1%
3,027,835
+142.1%
0.01%
+140.0%
Q1 2020$33,511,000
+38.2%
1,250,870
+58.0%
0.01%
+66.7%
Q4 2019$24,241,000
+15.1%
791,663
-9.5%
0.00%0.0%
Q3 2019$21,065,000
+18.9%
874,412
+25.1%
0.00%
+50.0%
Q2 2019$17,718,000
+33.6%
699,212
+2.8%
0.00%0.0%
Q1 2019$13,258,000
+39.8%
679,888
-5.4%
0.00%0.0%
Q4 2018$9,482,000
-41.4%
718,883
-21.1%
0.00%0.0%
Q3 2018$16,190,000
-23.5%
910,559
-5.3%
0.00%
-33.3%
Q2 2018$21,157,000961,6830.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders